The briefing
Researchers report an automated platform that combines cell‑free protein synthesis with AI‑driven design to optimize enzyme output. The approach targets faster, more efficient biocatalyst development for pharmaceuticals, chemicals, food, and cosmetics.
Original headline
Automated platform optimizes enzyme production using cell-free protein synthesis and AI-driven design